Maybe. Doesn't always work like that though. In this market downturn there are a handful of companies that have smaller market caps than they have cash in the bank.
It would be cash on balance sheet and would conceptually add value, but the market cap is determined by how the market values the stock. I think the value is in future approvals so cash on balance sheet probably wouldn’t move the needle proportionately, IMO. It could be used to fund trials or pay down debt. Who knows if any would go to individual shareholders
they are claiming damages in excess of 49 million shares sold at depressed prices, lets say 50 cents, which should have been lets say $5? The difference is then $220 million. So how would they be able to claim $ 500 million in damages suffered?
does that value translate into increased overall company value of 0.5 billion, which should then be reflected in the stock price?
absolutely for one we dont need to get diluted anymore